U.S. Federal Trade Commission Clears Teva Pharmaceutical Industries Limited (TEVA) And IVAX Corporation (IVX) Merger; Closing Scheduled For January 26, 2006  
1/23/2006 2:21:33 PM

JERUSALEM & MIAMI--(BUSINESS WIRE)--Jan. 23, 2006--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and IVAX Corporation (AMEX: IVX) announced today that the U.S. Federal Trade Commission ("FTC") has accepted the proposed consent order for public comment and granted early termination of the Hart Scott Rodino waiting period, thereby permitting the parties to close the transaction.